Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants
Yomi® S and YomiPlan® AI Platform Now FDA-Cleared, Offering Unprecedented Precision, Efficiency, and Access for Dentists and Patients
MIAMI, Nov. 17, 2025 (GLOBE NEWSWIRE) — Neocis®, the pioneer behind the first and only U.S. FDA-cleared robotic system for dental implant surgery, today announced the launch and FDA approval of its next-generation robotic platform: Yomi S. The new system, powered by advanced AI software YomiPlan, redefines what’s possible in dental surgery—delivering surgical precision, streamlined workflows, and high-quality patient outcomes.
Designed for maximum efficiency and minimal invasiveness, Yomi S can now be operated by a single practitioner via foot pedal and touchscreen—freeing up staff resources and making robotic-assisted implant surgery more accessible to general dentists. The system features a smaller footprint, enhanced dexterity, better visibility, and a new AI-powered planning suite that automates complex preoperative tasks.
